Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in J Lipid Res

Retrieve available abstracts of 9 articles:
HTML format

Single Articles

    May 2022
  1. RODRIGUEZ-GUTIERREZ R, Gonzalez JG, Parmar D, Shaikh F, et al
    Saroglitazar is non-inferior to fenofibrate in reducing triglyceride levels in hypertriglyceridemic patients in a randomized clinical trial.
    J Lipid Res. 2022 May 20:100233. doi: 10.1016/j.jlr.2022.100233.
    PubMed     Abstract available

    March 2022
  2. GOMES D, Wang S, Goodspeed L, Turk KE, et al
    Comparison between genetic and pharmaceutical disruption of Ldlr expression for the development of atherosclerosis.
    J Lipid Res. 2022;63:100174.
    PubMed     Abstract available

    January 2022
  3. MORTON RE, Mihna D
    Apolipoprotein F concentration, activity, and the properties of LDL controlling ApoF activation in hyperlipidemic plasma.
    J Lipid Res. 2022 Jan 8:100166. doi: 10.1016/j.jlr.2021.100166.
    PubMed     Abstract available

    October 2021
  4. FUTEMA M, Taylor-Beadling A, Williams M, Humphries SE, et al
    Genetic testing for Familial Hypercholesterolaemia - Past, Present and Future.
    J Lipid Res. 2021 Oct 16:100139. doi: 10.1016/j.jlr.2021.100139.
    PubMed     Abstract available

    The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer.
    J Lipid Res. 2021 Oct 1:100130. doi: 10.1016/j.jlr.2021.100130.
    PubMed     Abstract available

    March 2021
    Existing and emerging therapies for the treatment of familial hypercholesterolemia.
    J Lipid Res. 2021 Mar 11:100060. doi: 10.1016/j.jlr.2021.100060.
    PubMed     Abstract available

  7. CHEMELLO K, Garcia-Nafria J, Gallo A, Martin C, et al
    Lipoprotein Metabolism in Familial Hypercholesterolemia.
    J Lipid Res. 2021 Mar 3:100062. doi: 10.1016/j.jlr.2021.100062.
    PubMed     Abstract available

    January 2021
    FH through the retrospectoscope.
    J Lipid Res. 2021;62:100036.
    PubMed     Abstract available

    January 2020
    Combination ANGPTL3, PCSK9 and statin therapy drives remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model.
    J Lipid Res. 2020 Jan 24. pii: jlr.C120000650. doi: 10.1194/jlr.C120000650.

Thank you for your interest in scientific medicine.

AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.